These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Renin-angiotensin system activation in renal adipogenesis. Sui Y; Zhao HL; Fan RR; Guan J; He L; Lee HM; Chan JC; Tong PC Am J Physiol Renal Physiol; 2010 Feb; 298(2):F391-400. PubMed ID: 19940035 [TBL] [Abstract][Full Text] [Related]
4. Lipid partitioning after uninephrectomy. Zhao HL; Sui Y; He L; Guan J; Xiao SJ; Zhong DR; Xu Q; Zeng SE Acta Diabetol; 2011 Dec; 48(4):317-328. PubMed ID: 21528432 [TBL] [Abstract][Full Text] [Related]
5. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin inhibition stimulates PPARgamma and the release of visfatin. Storka A; Vojtassakova E; Mueller M; Kapiotis S; Haider DG; Jungbauer A; Wolzt M Eur J Clin Invest; 2008 Nov; 38(11):820-6. PubMed ID: 19021699 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction. Ahmad M; White R; Tan J; Huang BS; Leenen FH J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146 [TBL] [Abstract][Full Text] [Related]
8. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis. Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535 [TBL] [Abstract][Full Text] [Related]
9. ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats. Remuzzi A; Benigni A; Malanchini B; Bruzzi I; Foglieni C; Remuzzi G Kidney Int; 1995 May; 47(5):1319-26. PubMed ID: 7637261 [TBL] [Abstract][Full Text] [Related]
10. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis. Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682 [TBL] [Abstract][Full Text] [Related]
11. Interaction of renin-angiotensin system and adenosine monophosphate-activated protein kinase signaling pathway in renal carcinogenesis of uninephrectomized rats. Yang KK; Sui Y; Zhou HR; Zhao HL Tumour Biol; 2017 May; 39(5):1010428317699116. PubMed ID: 28459365 [TBL] [Abstract][Full Text] [Related]
12. Converting enzyme inhibition and renal function of conscious uninephrectomized rats [correction of enzyme]. MacLaughlin M; Campisi R; Amorena C Acta Physiol Pharmacol Ther Latinoam; 1996; 46(3):203-8. PubMed ID: 9201321 [TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin converting enzyme inhibitors on ischaemia-reperfusion-induced renal injury in rats. Krishan P; Sharma A; Singh M Pharmacol Res; 1998 Jan; 37(1):23-9. PubMed ID: 9503476 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril. Udupa EG; Rao NM Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic resistance to angiotensin converting enzyme (ACE) inhibition is related to pharmacodynamic and -kinetic factors in 5/6 nephrectomized rats. Windt WA; van Dokkum RP; Kluppel CA; Jeronimus-Stratingh CM; Hut F; de Zeeuw D; Henning RH Eur J Pharmacol; 2008 Feb; 580(1-2):231-40. PubMed ID: 18036585 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats. Remuzzi A; Malanchini B; Battaglia C; Bertani T; Remuzzi G Exp Nephrol; 1996; 4(1):19-25. PubMed ID: 8788596 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiotensin-converting enzyme and attenuation of myocardial fibrosis by lisinopril in rats receiving angiotensin II. Sun Y; Ratajska A; Weber KT J Lab Clin Med; 1995 Jul; 126(1):95-101. PubMed ID: 7602241 [TBL] [Abstract][Full Text] [Related]
18. Lisinopril as an antioxidant in hypertension? Polizio AH; Peña C Antioxid Redox Signal; 2007 Mar; 9(3):393-7. PubMed ID: 17184180 [TBL] [Abstract][Full Text] [Related]
19. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy. Remuzzi A; Fassi A; Bertani T; Perico N; Remuzzi G Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341 [TBL] [Abstract][Full Text] [Related]
20. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril. Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]